Tech Company Financing Transactions
Dermata Therapeutics Funding Round
On 2/17/2017, Dermata Therapeutics raised $10 million in Series A funding from Silicon Valley Bank and private investors.
Transaction Overview
Company Name
Announced On
2/17/2017
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$10,000,000
Round
Series A
Investors
Proceeds Purpose
Dermata intends to use the capital for general corporate purposes to further Dermata's mission of making major advancements in the treatment of serious diseases treated by dermatologists.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
3525 Del Mar Heights Rd. 322
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Website
Email Address
Overview
Dermata is a development-stage biotechnology company founded in late 2014 focused on making major advancements in the treatment of serious diseases treated by dermatologists, with a focus on inflammation and immunology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gerry Proehl
Chief Financial Officer
Thomas Insley
Vice President
Laura Weston
VP - Bus. Development
Chris Nardo
VP - General Counsel
Hazel Aker
VP - Product Management
Warren Hall
VP - Regulatory Affairs
Maria Bedoya Toro Munera
Browse more venture capital transactions:
Prev: 2/17/2017: Xcell Biosciences venture capital transaction
Next: 2/17/2017: MobiTV venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on funding rounds that are announced publicly. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs